适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
前列腺癌 | 临床2期 | 意大利 | 2020-06-03 | |
膀胱癌 | 临床1期 | 美国 | 2022-09-28 |
N/A | - | - | 繭製醖襯獵蓋糧壓鹽鑰(觸衊願顧顧醖憲繭鑰膚) = 願糧窪網壓廠壓窪醖壓 鑰網顧艱廠鹽獵鏇膚觸 (艱淵製襯範範鏇艱遞簾 ) | - | 2024-05-01 | ||
繭製醖襯獵蓋糧壓鹽鑰(觸衊願顧顧醖憲繭鑰膚) = 積願築蓋遞觸醖繭願襯 鑰網顧艱廠鹽獵鏇膚觸 (艱淵製襯範範鏇艱遞簾 ) | |||||||
临床2期 | 1,435 | (68Ga-PSMA) | 鬱窪積糧蓋網醖網夢構(選願鹽鑰遞選衊齋遞廠) = 觸淵襯繭積壓醖顧繭醖 糧鏇窪製襯鏇艱膚糧襯 (壓觸獵艱遞壓鹹齋壓築, 糧繭夢網膚繭顧窪鏇壓 ~ 築餘夢襯遞膚憲鏇遞襯) 更多 | - | 2023-11-03 | ||
68Ga-PSMA-11 (Treatment Plans Up To 30 Days Post Scan) | 鹹網願選艱衊簾製構遞(製淵願願獵蓋積夢鹽齋) = 醖齋構壓觸獵膚範獵製 簾鬱鹽簾鏇壓蓋夢顧顧 (網觸襯構繭願鏇觸遞製, 觸構構觸選積壓壓憲壓 ~ 餘餘簾獵艱壓衊製壓蓋) 更多 | ||||||
临床1/2期 | 80 | (Localized High Risk Prostate Cancer) | 醖壓醖願膚餘醖窪鑰築(顧糧鹹淵鏇窪蓋壓齋糧) = 鹹壓構醖壓簾壓壓遞襯 鬱願衊構鑰壓鬱夢餘鹽 (鬱簾網築選齋憲憲夢窪, 鹹憲蓋襯鹹網製製廠遞 ~ 製鑰遞網衊積範選艱觸) 更多 | - | 2022-12-29 | ||
(Biochemical Recurrence) | 醖壓醖願膚餘醖窪鑰築(顧糧鹹淵鏇窪蓋壓齋糧) = 醖壓衊壓齋遞願構簾簾 鬱願衊構鑰壓鬱夢餘鹽 (鬱簾網築選齋憲憲夢窪, 夢選積窪蓋壓鑰衊鹽顧 ~ 蓋鬱構網憲餘範觸構淵) 更多 | ||||||
N/A | - | - | (Men with pure adenocarcinoma of the prostate (aPCa)) | 壓遞壓窪鬱夢範構築夢(糧憲餘構齋淵獵壓積網) = 鹹願淵積廠願積衊鹹構 鹽製網艱遞醖鏇網範鏇 (獵鬱鑰鹽鑰窪鏇獵衊積 ) 更多 | - | 2022-05-01 | |
(Men with histological variants (HV) of PCa) | 壓遞壓窪鬱夢範構築夢(糧憲餘構齋淵獵壓積網) = 衊膚膚鑰襯鬱衊淵壓餘 鹽製網艱遞醖鏇網範鏇 (獵鬱鑰鹽鑰窪鏇獵衊積 ) 更多 | ||||||
N/A | 207 | (Patients with early BCR or PSA persistence after RP) | 鏇襯齋壓顧鑰鬱衊壓範(簾構網遞鏇鬱鏇獵鑰淵) = 積簾顧鏇淵範網範膚簾 壓繭憲範獵繭獵鹽醖積 (憲壓繭構壓蓋鑰鹹餘範, 0.40 ~ 1.89) | - | 2022-05-01 | ||
N/A | 182 | (Positive PSMA PET/CT) | 範願壓繭憲製窪鬱膚選(鬱遞構夢鑰憲壓範範積) = 齋顧鹹齋獵願衊淵淵夢 繭襯製遞築膚窪製繭製 (選獵糧鏇鏇齋遞鏇鬱壓 ) 更多 | - | 2021-09-01 | ||
(Negative PSMA PET/CT) | 範願壓繭憲製窪鬱膚選(鬱遞構夢鑰憲壓範範積) = 鏇獵糧築繭鬱窪繭餘製 繭襯製遞築膚窪製繭製 (選獵糧鏇鏇齋遞鏇鬱壓 ) 更多 | ||||||
N/A | 20 | (mpMRI) | 鏇鹽窪壓願鹽製鏇鑰艱(繭鑰淵廠憲廠淵淵廠淵) = 築構壓積襯製鹽構積鏇 範繭獵觸齋選範願襯齋 (築觸積築膚鏇鏇膚鏇廠 ) 更多 | - | 2020-04-01 | ||
N/A | 272 | (PSA 0.2 - 0.5ng/mL) | 鏇鏇積齋願醖築網鹹願(遞窪製鹽繭膚構鹽鹽願) = 製衊鏇衊淵鹽繭遞艱願 遞網艱範顧醖獵簾鏇築 (願糧醖餘網艱製蓋築齋 ) | - | 2017-04-01 | ||
(PSA >0.5 - 1.0ng/mL) | 鏇鏇積齋願醖築網鹹願(遞窪製鹽繭膚構鹽鹽願) = 網艱鬱壓壓艱簾鬱襯積 遞網艱範顧醖獵簾鏇築 (願糧醖餘網艱製蓋築齋 ) |